Prognostic Stage IIB Breast Cancer AJCC v8 Recruiting Phase 2 Trials for Anastrozole (DB01217)

IndicationStatusPhase
DBCOND0109634 (Prognostic Stage IIB Breast Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04294225Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast CancerTreatment